Tag: CNK

  • BioCryst Pharmaceuticals Reports Lower Loss (TW, BCRX, DISH, CNK)

    BioCryst Pharmaceuticals Reports Lower Loss (TW, BCRX, DISH, CNK)

    Towers Watson & Co (NYSE:TW) reported third quarter income of $68.2 million, as compared to $69.2 million a year earlier. With fewer shares outstanding, earnings were $0.95 a share, versus $0.94 a share in the year-ago period. Adjusted per-share earnings rose to $1.39 from $1.37. Revenue rose 4.1% to $901.5 million. The company in February had predicted adjusted earnings of $1.31 to $1.36 a share on revenue of $875 million to $900 million.

    Looking forward, the company raised its full-year earnings guidance, now calling for a per-share profit of $5.14 to $5.19, from its previously seen $5.05 to $5.15.

    BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) first quarter revenues increased to $12.2 million from $5.4 million in last year’s quarter. The large increase in revenue for the quarter relates to the recognition of $7.8 million of forodesine-related revenue. The net loss for the first quarter was $6.1 million, or $0.13 per share, as compared to a net loss of $13.0 million, or $0.29 per share, for the first quarter 2011.

    DISH Network Corp. (NASDAQ:DISH) reported a first quarter profit of $360.3 million, or $0.80 a share, as compared to $549.4 million, or $1.22, a year earlier. Revenue jumped 11% to $3.58 billion. Analysts expected earnings of $0.70 a share on revenue of $3.62 billion. Operating margin dropped to 16% from 30.5%.

    The company added 104,000 net subscribers during the first quarter, though its customer base slipped 0.8% to 14.1 million from 14.2 million a year earlier.

    Cinemark Holdings, Inc. (NYSE:CNK) reported a first-quarter net income of $42.1 million, as against $25 million earned a year ago. Earnings per share grew to $0.37 from $0.22 in the prior year. Quarterly revenues improved to $578.8 million from $483.1 million in the same quarter a year ago. Analysts expected the company to earn $0.34 per share on revenues of $571.96 million for the quarter. Operating margin widened to 15.5% from 10.1%.